In an amended filing made with the regulatory on Wednesday morning, Anthera Pharmaceuticals, Inc. disclosed that it estimates pricing initial public offering of 4.607 million shares of common stock between $13 and $15 per share.
In an amended filing made with the regulatory on Wednesday morning, Anthera Pharmaceuticals, Inc. disclosed that it estimates pricing initial public offering of 4.607 million shares of common stock between $13 and $15 per share.